Magdalena Plebanski

16.2k total citations · 4 hit papers
252 papers, 11.6k citations indexed

About

Magdalena Plebanski is a scholar working on Immunology, Molecular Biology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Magdalena Plebanski has authored 252 papers receiving a total of 11.6k indexed citations (citations by other indexed papers that have themselves been cited), including 139 papers in Immunology, 93 papers in Molecular Biology and 67 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Magdalena Plebanski's work include Immunotherapy and Immune Responses (68 papers), Malaria Research and Control (54 papers) and Immune Cell Function and Interaction (47 papers). Magdalena Plebanski is often cited by papers focused on Immunotherapy and Immune Responses (68 papers), Malaria Research and Control (54 papers) and Immune Cell Function and Interaction (47 papers). Magdalena Plebanski collaborates with scholars based in Australia, United Kingdom and Gambia. Magdalena Plebanski's co-authors include Sue D. Xiang, Katie L. Flanagan, Patricia L. Mottram, Anja Scholzen, Vasso Apostolopoulos, Gabriela Minigo, Adrian V. S. Hill, Michael Quinn, Mutsa Madondo and Sarah C. Gilbert and has published in prestigious journals such as Nature, Science and Proceedings of the National Academy of Sciences.

In The Last Decade

Magdalena Plebanski

248 papers receiving 11.4k citations

Hit Papers

Size-Dependent Immunogenicity: Therapeutic and Protective... 2004 2026 2011 2018 2004 2015 2017 2021 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Size-Dependent Immunogenicity: Therapeutic and Protective Properties of Nano-Vaccines against Tumors
    2004 515 citations Theodora Fifis, Magdalena Plebanski et al. profile →
  2. Two-dimensional single-cell patterning with one cell per well driven by surface acoustic waves
    2015 488 citations Magdalena Plebanski et al. profile →
  3. Sex and Gender Differences in the Outcomes of Vaccination over the Life Course
    2017 341 citations Katie L. Flanagan, Magdalena Plebanski et al. profile →
  4. Tumor-Induced Inflammatory Cytokines and the Emerging Diagnostic Devices for Cancer Detection and Prognosis
    2021 222 citations Apriliana E. R. Kartikasari, Magdalena Plebanski et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Magdalena Plebanski Australia 57 5.1k 4.1k 2.4k 1.2k 1.2k 252 11.6k
István Tóth Australia 58 3.6k 0.7× 7.5k 1.8× 1.7k 0.7× 1.2k 1.0× 1.9k 1.7× 547 14.3k
Peter Garred Denmark 71 11.2k 2.2× 2.5k 0.6× 1.5k 0.6× 2.5k 2.0× 2.0k 1.7× 416 17.2k
Siegfried Weiß Germany 55 5.7k 1.1× 3.1k 0.8× 546 0.2× 1.3k 1.1× 1.3k 1.1× 180 10.6k
Hirofumi Sawa Japan 50 2.5k 0.5× 4.5k 1.1× 964 0.4× 1.5k 1.2× 2.0k 1.8× 362 11.4k
Manuel E. Patarroyo Colombia 61 5.3k 1.0× 5.1k 1.3× 4.9k 2.0× 2.8k 2.3× 1.7k 1.5× 504 14.8k
Carl R. Alving United States 59 4.4k 0.9× 4.4k 1.1× 1.1k 0.5× 1.4k 1.1× 1.3k 1.1× 261 10.7k
Hui Wang China 62 3.7k 0.7× 6.7k 1.6× 605 0.2× 2.1k 1.7× 1.2k 1.0× 708 16.0k
Hongmin Li China 48 1.9k 0.4× 2.9k 0.7× 1.5k 0.6× 755 0.6× 1.7k 1.4× 276 8.3k
Eckhard R. Podack United States 64 9.0k 1.8× 3.9k 1.0× 934 0.4× 1.4k 1.1× 627 0.5× 254 14.0k
Jianzhu Chen United States 61 7.9k 1.5× 5.4k 1.3× 604 0.2× 1.3k 1.1× 1.1k 1.0× 211 14.9k

Countries citing papers authored by Magdalena Plebanski

Since Specialization
Citations

This map shows the geographic impact of Magdalena Plebanski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Magdalena Plebanski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Magdalena Plebanski more than expected).

Fields of papers citing papers by Magdalena Plebanski

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Magdalena Plebanski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Magdalena Plebanski. The network helps show where Magdalena Plebanski may publish in the future.

Co-authorship network of co-authors of Magdalena Plebanski

This figure shows the co-authorship network connecting the top 25 collaborators of Magdalena Plebanski. A scholar is included among the top collaborators of Magdalena Plebanski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Magdalena Plebanski. Magdalena Plebanski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Srivastava, Sapna, et al.. (2025). IGSF11-Mediated Immune Modulation: Unlocking a Novel Pathway in Emerging Cancer Immunotherapies. Cancers. 17(16). 2636–2636. 1 indexed citations
2.
Krohn, Christian, Daniel A. Dias, Catherine A. Rees, et al.. (2024). Dead in the water – Role of relic DNA and primer choice for targeted sequencing surveys of anaerobic sewage sludge intended for biological monitoring. Water Research. 253. 121354–121354. 6 indexed citations
3.
Saadati, Saeede, Maximilian de Courten, Magdalena Plebanski, et al.. (2024). Carnosine Supplementation Has No Effect on Inflammatory Markers in Adults with Prediabetes and Type 2 Diabetes: A Randomised Controlled Trial. Nutrients. 16(22). 3900–3900. 4 indexed citations
4.
Ju, Yi, Shiyao Li, Emily H. Pilkington, et al.. (2024). Patient-Specific Nanoparticle Targeting in Human Leukemia Blood. ACS Nano. 18(42). 29021–29035. 19 indexed citations
5.
Kampan, Nirmala Chandralega, Catherine Itsiopoulos, Katie L. Flanagan, et al.. (2024). Interleukin-6 Modulation in Ovarian Cancer Necessitates a Targeted Strategy: From the Approved to Emerging Therapies. Cancers. 16(24). 4187–4187. 3 indexed citations
6.
Zheng, Zhen, Stephen R. Bird, Magdalena Plebanski, et al.. (2023). An Overview of Long COVID Support Services in Australia and International Clinical Guidelines, With a Proposed Care Model in a Global Context. Public health reviews. 44. 1606084–1606084. 3 indexed citations
7.
Boer, Jennifer C., Mattaka Khongkow, Sarunya Phunpee, et al.. (2023). The Development of Surface-Modified Liposomes as an Intranasal Delivery System for Group A Streptococcus Vaccines. Vaccines. 11(2). 305–305. 5 indexed citations
8.
Boer, Jennifer C., Zeinab G. Khalil, Ahmed O. Shalash, et al.. (2023). Polymeric Nanoparticles as a Self‐Adjuvanting Peptide Vaccine Delivery System: The Role of Shape. Advanced Functional Materials. 33(12). 13 indexed citations
9.
Kampan, Nirmala Chandralega, Apriliana E. R. Kartikasari, Mutsa Madondo, et al.. (2023). Combining TNFR2-Expressing Tregs and IL-6 as Superior Diagnostic Biomarkers for High-Grade Serous Ovarian Cancer Masses. Cancers. 15(3). 667–667. 6 indexed citations
10.
Azuar, Armira, Jennifer C. Boer, Jazmina L. Gonzalez Cruz, et al.. (2022). Poly(hydrophobic Amino Acids) and Liposomes for Delivery of Vaccine against Group A Streptococcus. Vaccines. 10(8). 1212–1212. 9 indexed citations
11.
Hartley, Gemma E., Emily S.J. Edwards, Julian J. Bosco, et al.. (2020). Influenza‐specific IgG1+ memory B‐cell numbers increase upon booster vaccination in healthy adults but not in patients with predominantly antibody deficiency. Clinical & Translational Immunology. 9(10). e1199–e1199. 12 indexed citations
12.
Skwarczyński, Mariusz, Jennifer C. Boer, Victoria Ozberk, et al.. (2020). Poly(amino acids) as a potent self-adjuvanting delivery system for peptide-based nanovaccines. Science Advances. 6(5). eaax2285–eaax2285. 90 indexed citations
13.
Draxler, Dominik F., Maria Daglas, Heidi Ho, et al.. (2019). Tranexamic acid modulates the immune response and reduces postsurgical infection rates. Blood Advances. 3(10). 1598–1609. 79 indexed citations
14.
Mousa, Aya, Negar Naderpoor, Josphin Johnson, et al.. (2017). Effect of vitamin D supplementation on inflammation and nuclear factor kappa-B activity in overweight/obese adults: a randomized placebo-controlled trial. Scientific Reports. 7(1). 15154–15154. 43 indexed citations
15.
Kempe, Kristian, Sue D. Xiang, Paul Wilson, et al.. (2017). Engineered Hydrogen-Bonded Glycopolymer Capsules and Their Interactions with Antigen Presenting Cells. ACS Applied Materials & Interfaces. 9(7). 6444–6452. 19 indexed citations
16.
17.
Pouniotis, Dodie, et al.. (2004). Dendritic Cells Induce Immunity and Long-Lasting Protection against Blood-Stage Malaria despite an In Vitro Parasite-Induced Maturation Defect. Infection and Immunity. 72(9). 5331–5339. 48 indexed citations
18.
Plebanski, Magdalena, et al.. (2002). Immunogenetics and the design of Plasmodium falciparum vaccines for use in malaria-endemic populations. Journal of Clinical Investigation. 110(3). 295–301. 11 indexed citations
19.
Plebanski, Magdalena, et al.. (2002). Immunogenetics and the design of Plasmodium falciparum vaccines for use in malaria-endemic populations. Journal of Clinical Investigation. 110(3). 295–301. 15 indexed citations
20.
Flanagan, Katie L., Magdalena Plebanski, William H. H. Reece, et al.. (1999). Broadly distributed T cell reactivity, with no immunodominant loci, to the pre-erythrocytic antigen thrombospondin-related adhesive protein ofPlasmodium falciparum in West Africans. European Journal of Immunology. 29(6). 1943–1954. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by István Tóth Breakdown of academic impact, for papers by Peter Garred Breakdown of academic impact, for papers by Siegfried Weiß Breakdown of academic impact, for papers by Hirofumi Sawa Breakdown of academic impact, for papers by Manuel E. Patarroyo Breakdown of academic impact, for papers by Carl R. Alving Breakdown of academic impact, for papers by Hui Wang Breakdown of academic impact, for papers by Hongmin Li Breakdown of academic impact, for papers by Eckhard R. Podack Breakdown of academic impact, for papers by Jianzhu Chen
Rankless by CCL
2026